Cetuximab and Irinotecan as Third-Line Therapy in Advanced Colorectal Cancer Patients: A Single Centre Phase II Trial
British Journal of Cancer - United Kingdom
doi 10.1038/sj.bjc.6603018
Full Text
Open PDFAbstract
Available in full text
Date
February 28, 2006
Authors
Publisher
Springer Science and Business Media LLC